Continuation of follow-up of DES-exposed cohort

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000121C
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value 0% obligated
  • $266,751.00 Current, with exercised options
  • $1,314,591.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Chicago, IL 60637, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 -$266,751
Original award $266,751

About this award

This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to the University of Chicago for the continuation of follow-up of a cohort exposed to Diethylstilbestrol (DES). The contract has a ceiling value of $1,314,591.00 and does not have a set-aside designation. The contract type is cost no fee, and the ultimate completion date is September 29, 2015.

Quick answers

Who was awarded contract HHSN261201000121C?

HHSN261201000121C was awarded to The University Of Chicago by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000121C worth?

The government has obligated $0 on HHSN261201000121C. Its current value, with exercised options, is $266,751. Its potential value, with all options, is $1,314,591.

Was contract HHSN261201000121C competed?

The extent of competition for HHSN261201000121C was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award